Han GH

No ORCID on file · 4 papers in corpus
other 2025
Association Between Levonorgestrel-Releasing Intrauterine System Exposure Duration and Breast Cancer Incidence
Obstetrics and gynecology ·doi:10.1097/AOG.0000000000005881

OBJECTIVE: To investigate the association between the duration of levonorgestrel-releasing intrauterine system (LNG-IUS) use and breast cancer risk in Korean women. METHODS: A retrospective cohort study was conducted using the Korean Natio…

2024
Menopausal Hormone Therapy and Osteoarthritis Risk: Retrospective Population-Based Study in South Korea.
Journal of menopausal medicine ·doi:10.6118/jmm.24014

ObjectivesThis study aimed to investigate the risk of osteoarthritis associated with menopausal hormone therapy (MHT).MethodsThis population-based retrospective cohort study used a database of Korean health insurance claims (2007-2020). Fem…

2023
Case Report: Upper limb superficial venous thrombosis associated with oral contraceptives mimicking soft tissue mass.
Frontiers in cardiovascular medicine ·doi:10.3389/fcvm.2023.1263662

BackgroundVenous thrombosis associated with the use of oral contraceptives (OCs) occurs mostly in the deep veins of the lower extremity. A lesion of the upper extremity is rare, and the majority of thrombotic events that occur in the superf…

2022
NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells.
Journal of cellular and molecular medicine ·doi:10.1111/jcmm.17557

NANOG engages with tumour initiation and metastasis by regulating the epithelial-mesenchymal transition (EMT) in epithelial ovarian cancer (EOC). However, its role in association with pAMPKα, and its clinical significance in EOC have not be…